Gene Editing
The clinical application and regulatory strategy of genome editing for ex vivo cell therapy is derived from the intersection of two fields of study: viral vector gene therapy trials; and clinical…
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
Gene therapy using autologous or allogeneic cells offers promising possibilities to treat inherited and acquired diseases, ideally leading to a long-lasting therapeutic correction. This article summarizes efforts that use integrating…
Nonintegrating Gene Therapy Vectors
Gene delivery vectors that do not rely on host cell genome integration offer several advantages for gene transfer, chiefly the avoidance of insertional mutagenesis and position effect variegation. However, unless…
Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy
Gene therapy using hematopoietic stem cells (HSC) has developed over the past 3 decades, with progressive improvements in the efficacy and safety. Autologous transplantation of HSC modified with murine gammaretroviral…
Gene Therapy
Daniel E. Bauer, MD, PhD, Editor Related posts: In Vivo Hematopoietic Stem Cell Transduction Therapeutic Gene Editing Safety and Specificity Opening Marrow Niches in Patients Undergoing Autologous Hematopoietic Stem Cell Gene…
